UniProt ID | SPIN1_HUMAN | |
---|---|---|
UniProt AC | Q9Y657 | |
Protein Name | Spindlin-1 | |
Gene Name | SPIN1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 262 | |
Subcellular Localization | Nucleus . Nucleus, nucleolus . | |
Protein Description | Chromatin reader that specifically recognizes and binds histone H3 both trimethylated at 'Lys-4' and asymmetrically dimethylated at 'Arg-8' (H3K4me3 and H3R8me2a) and acts as an activator of Wnt signaling pathway downstream of PRMT2. In case of cancer, promotes cell cancer proliferation via activation of the Wnt signaling pathway. [PubMed: 24589551 Overexpression induces metaphase arrest and chromosomal instability. Localizes to active rDNA loci and promotes the expression of rRNA genes] | |
Protein Sequence | MKTPFGKTPGQRSRADAGHAGVSANMMKKRTSHKKHRSSVGPSKPVSQPRRNIVGCRIQHGWKEGNGPVTQWKGTVLDQVPVNPSLYLIKYDGFDCVYGLELNKDERVSALEVLPDRVATSRISDAHLADTMIGKAVEHMFETEDGSKDEWRGMVLARAPVMNTWFYITYEKDPVLYMYQLLDDYKEGDLRIMPDSNDSPPAEREPGEVVDSLVGKQVEYAKEDGSKRTGMVIHQVEAKPSVYFIKFDDDFHIYVYDLVKTS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Methylation | ------MKTPFGKTP ------CCCCCCCCC | 65.98 | 30592611 | |
3 | Phosphorylation | -----MKTPFGKTPG -----CCCCCCCCCC | 23.66 | 21712546 | |
7 | Methylation | -MKTPFGKTPGQRSR -CCCCCCCCCCCCCC | 52.50 | 24129315 | |
7 | Acetylation | -MKTPFGKTPGQRSR -CCCCCCCCCCCCCC | 52.50 | 19608861 | |
7 | Sumoylation | -MKTPFGKTPGQRSR -CCCCCCCCCCCCCC | 52.50 | 28112733 | |
8 | Phosphorylation | MKTPFGKTPGQRSRA CCCCCCCCCCCCCCC | 32.79 | 28555341 | |
13 | Phosphorylation | GKTPGQRSRADAGHA CCCCCCCCCCCCCCC | 24.75 | 20068231 | |
23 | Phosphorylation | DAGHAGVSANMMKKR CCCCCCCCHHHHHHC | 17.01 | 20068231 | |
28 | Acetylation | GVSANMMKKRTSHKK CCCHHHHHHCCCCCC | 28.47 | 25953088 | |
28 | Sumoylation | GVSANMMKKRTSHKK CCCHHHHHHCCCCCC | 28.47 | 28112733 | |
29 | Acetylation | VSANMMKKRTSHKKH CCHHHHHHCCCCCCC | 42.91 | 26051181 | |
31 | Phosphorylation | ANMMKKRTSHKKHRS HHHHHHCCCCCCCHH | 44.02 | 20068231 | |
32 | Phosphorylation | NMMKKRTSHKKHRSS HHHHHCCCCCCCHHC | 37.02 | 20068231 | |
38 | Phosphorylation | TSHKKHRSSVGPSKP CCCCCCHHCCCCCCC | 29.15 | 23927012 | |
39 | Phosphorylation | SHKKHRSSVGPSKPV CCCCCHHCCCCCCCC | 30.93 | 23927012 | |
43 | Phosphorylation | HRSSVGPSKPVSQPR CHHCCCCCCCCCCCC | 43.60 | 20068231 | |
44 | Sumoylation | RSSVGPSKPVSQPRR HHCCCCCCCCCCCCC | 53.20 | 28112733 | |
44 | Ubiquitination | RSSVGPSKPVSQPRR HHCCCCCCCCCCCCC | 53.20 | - | |
44 | Acetylation | RSSVGPSKPVSQPRR HHCCCCCCCCCCCCC | 53.20 | 23236377 | |
47 | Phosphorylation | VGPSKPVSQPRRNIV CCCCCCCCCCCCCEE | 42.89 | 27251275 | |
63 | Ubiquitination | CRIQHGWKEGNGPVT EEECCCCCCCCCCCC | 61.41 | 21890473 | |
63 | Ubiquitination | CRIQHGWKEGNGPVT EEECCCCCCCCCCCC | 61.41 | 21890473 | |
63 | Ubiquitination | CRIQHGWKEGNGPVT EEECCCCCCCCCCCC | 61.41 | 21890473 | |
91 | Phosphorylation | PSLYLIKYDGFDCVY CCEEEEEECCCCEEE | 17.82 | 17053785 | |
98 | Phosphorylation | YDGFDCVYGLELNKD ECCCCEEEEEECCCC | 23.48 | 17053785 | |
104 | Ubiquitination | VYGLELNKDERVSAL EEEEECCCCCCEEEE | 73.85 | - | |
109 | Phosphorylation | LNKDERVSALEVLPD CCCCCCEEEEEECCC | 33.10 | 22258766 | |
120 | Phosphorylation | VLPDRVATSRISDAH ECCCHHHHCCCCHHH | 18.71 | 23401153 | |
121 | Phosphorylation | LPDRVATSRISDAHL CCCHHHHCCCCHHHH | 20.20 | 20068231 | |
124 | Phosphorylation | RVATSRISDAHLADT HHHHCCCCHHHHHHH | 27.86 | 29255136 | |
131 | Phosphorylation | SDAHLADTMIGKAVE CHHHHHHHHHHHHHH | 12.70 | 29396449 | |
177 | Phosphorylation | YEKDPVLYMYQLLDD EECCCEEEEEEECCH | 8.26 | 20049867 | |
179 | Phosphorylation | KDPVLYMYQLLDDYK CCCEEEEEEECCHHH | 5.18 | 20049867 | |
185 | Phosphorylation | MYQLLDDYKEGDLRI EEEECCHHHCCCEEE | 15.59 | 20049867 | |
186 | Ubiquitination | YQLLDDYKEGDLRIM EEECCHHHCCCEEEC | 63.31 | - | |
196 | Phosphorylation | DLRIMPDSNDSPPAE CEEECCCCCCCCCCC | 36.34 | 30266825 | |
199 | Phosphorylation | IMPDSNDSPPAEREP ECCCCCCCCCCCCCC | 36.71 | 29255136 | |
212 | Phosphorylation | EPGEVVDSLVGKQVE CCCCHHHHHCCCEEE | 17.22 | 30108239 | |
216 | Ubiquitination | VVDSLVGKQVEYAKE HHHHHCCCEEEEECC | 43.63 | - | |
222 | Acetylation | GKQVEYAKEDGSKRT CCEEEEECCCCCCCC | 56.27 | 155779 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SPIN1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SPIN1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ANM6_HUMAN | PRMT6 | physical | 23455924 | |
SPIN4_HUMAN | SPIN4 | physical | 26186194 | |
SP16H_HUMAN | SUPT16H | physical | 26186194 | |
BCLF1_HUMAN | BCLAF1 | physical | 26186194 | |
TR150_HUMAN | THRAP3 | physical | 26186194 | |
CGBP1_HUMAN | CGGBP1 | physical | 26186194 | |
SSRP1_HUMAN | SSRP1 | physical | 26186194 | |
YRDC_HUMAN | YRDC | physical | 26186194 | |
CK084_HUMAN | C11orf84 | physical | 26186194 | |
MCM2_HUMAN | MCM2 | physical | 26186194 | |
ZGPAT_HUMAN | ZGPAT | physical | 26186194 | |
SF3A3_HUMAN | SF3A3 | physical | 26186194 | |
SCNM1_HUMAN | SCNM1 | physical | 26186194 | |
TOPRS_HUMAN | TOPORS | physical | 26186194 | |
PAX3_HUMAN | PAX3 | physical | 26186194 | |
CK084_HUMAN | C11orf84 | physical | 28514442 | |
CGBP1_HUMAN | CGGBP1 | physical | 28514442 | |
YRDC_HUMAN | YRDC | physical | 28514442 | |
TOPRS_HUMAN | TOPORS | physical | 28514442 | |
SCNM1_HUMAN | SCNM1 | physical | 28514442 | |
ZGPAT_HUMAN | ZGPAT | physical | 28514442 | |
PAX3_HUMAN | PAX3 | physical | 28514442 | |
SF3A3_HUMAN | SF3A3 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-7, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-124 AND SER-199, ANDMASS SPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-38 AND SER-39, AND MASSSPECTROMETRY. | |
"Tyrosine phosphorylated Par3 regulates epithelial tight junctionassembly promoted by EGFR signaling."; Wang Y., Du D., Fang L., Yang G., Zhang C., Zeng R., Ullrich A.,Lottspeich F., Chen Z.; EMBO J. 25:5058-5070(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-91 AND TYR-98, AND MASSSPECTROMETRY. |